Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MICHAEL SETH ALTMAN Insider Profile
4 Followers
MICHAEL SETH ALTMAN, Director at Lyra Therapeutics, holds ― shares in Lyra Therapeutics (Ticker: LYRA), holds 0.00 shares in Adagio Medical Holdings (Ticker: ADGM), holds 286.25K shares in Perceptive Capital Solutions Corp Class A (Ticker: PCSC). Most recently, MICHAEL SETH ALTMAN ― shares of Lyra Therapeutics on ― for an estimated value of ―.
MICHAEL SETH ALTMAN has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that MICHAEL SETH ALTMAN holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by MICHAEL SETH ALTMAN
MICHAEL SETH ALTMAN's Trading History
Lyra Therapeutics
―
Director
―
―
Nautilus Biotechnolgy
Jun 11, 2021
Director
Uninformative Buy
―
$1.24M
Adagio Medical Holdings
Jul 31, 2024
CFO, Director, Ten Percent Owner
Uninformative Sell
―
$0.00
ARYA Sciences Acquisition V
Jul 15, 2021
―
Uninformative Buy
4.99M
$5.17M
Perceptive Capital Solutions Corp Class A
Jun 13, 2024
Chief Business Officer, Director, Ten Percent Owner
Uninformative Buy
2.86M
$2.89M
List of latest transactions for each holding click on a transaction to see MICHAEL SETH ALTMAN's performance on stock
You May Also Like
MICHAEL SETH ALTMAN insider profile FAQ
What is the percentage of profitable transactions made by MICHAEL SETH ALTMAN?
The percentage of profitable transactions made by MICHAEL SETH ALTMAN is ―.
What is the average return per transaction made by MICHAEL SETH ALTMAN?
The average return per transaction made by MICHAEL SETH ALTMAN is ―.
What stocks does MICHAEL SETH ALTMAN hold?
MICHAEL SETH ALTMAN holds: LYRA, NAUT, ADGM, ARYE, PCSC stocks.
What was MICHAEL SETH ALTMAN’s latest transaction?
MICHAEL SETH ALTMAN latest transaction was an Uninformative Buy of ―.
What was MICHAEL SETH ALTMAN's most profitable transaction?
MICHAEL SETH ALTMAN’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is MICHAEL SETH ALTMAN's role in Lyra Therapeutics?
MICHAEL SETH ALTMAN's role in Lyra Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.